Loading chat...

MN SF3400

Bill

Status

Introduced

2/20/2020

Primary Sponsor

Rich Draheim

Click for details

Origin

Senate

91st Legislature 2019-2020

AI Summary

  • Pharmacy benefit managers and health carriers are prohibited from requiring or preferring specific pharmacies or providers for prescribing or dispensing reference biological products, biosimilar products, or interchangeable biological products.

  • If a pharmacy benefit manager or health carrier covers any one of these three product types, it must provide equivalent coverage for all three types.

  • Patients cannot be required to switch from a prescribed biological product to a different product with a higher retail price.

  • Defines "biosimilar product" as a biological product the FDA has licensed and determined to be biosimilar or therapeutically equivalent under federal law.

  • Requires medical assistance and MinnesotaCare drug coverage and reimbursement to comply with the biological products choice provisions.

Legislative Description

Pharmacy and provider choice related to prescribing and dispensing of biological products authorization

Last Action

Author added Klein

3/16/2020

Committee Referrals

Health and Human Services Finance and Policy2/20/2020

Full Bill Text

No bill text available